基于EEG的增强阿尔茨海默病检测,使用同步挤压转换和深度转移学习.
Shraddha Jain1, Rajeev Srivastava1
1Department of Computer Science and Engineering, Indian Institute of Technology (IIT), BHU, Varanasi Uttar Pradesh, India, 221011.
Neuroscience
|April 26, 2025
概括
这项研究引入了一种使用电脑电图 (EEG) 信号的先进阿尔茨海默氏症检测方法. 该模型通过分析脑电波模式,在识别阿尔茨海默病方面实现了高准确性.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病是一种进展性神经退行性疾病,影响记忆,认知和行为.
- 早期和准确的检测对于管理疾病对日常运作的影响至关重要.
研究的目的:
- 开发和评估基于脑电图 (EEG) 的分类模型,用于阿尔茨海默病的检测.
- 为了比较不同预训练的卷积神经网络 (CNN) 的性能来分类EEG信号.
主要方法:
- 用同步挤压技术将EEG信号转化为图像模式.
- 用精细调的预训练CNN (SqueezeNet,ResNet,InceptionV3,MobileNet) 来对这些EEG图像进行分类.
- 使用来自19个头皮电极的信号来评估分类性能,重点关注P3和T5通道.
主要成果:
- 发明V3模型显示了最高的分类准确性,在P3频道达到98.50%,在T5频道达到97.57%.
- 确定P3和T5通道是对阿尔茨海默氏症检测最有效的.
- 该研究证实,叶和叶的电活动反映了典型的疾病动态.
结论:
- 使用同步挤压和CNN的拟议的基于EEG的分类模型显示了用于准确检测阿尔茨海默病的显著潜力.
- 这些发现突出了特定EEG通道 (P3,T5) 和InceptionV3架构对此诊断任务的有效性.
- 这种方法提供了一种非侵入性的方法来识别阿尔茨海默病,反映了潜在的皮质电活动模式.
更多相关视频
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
39.7K
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
931
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21